An Overview of Systematic Reviews of Chinese Herbal Medicine for Alzheimer’s Disease

Background: Multiple systematic reviews (SRs) have been conducted to evaluate the efficacy and safety of Chinese herbal medicine (CHM) in patients with Alzheimer’s disease (AD). Here, we aim to perform an overview to assess the methodological quality and quality of evidence of the SRs to provide con...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nanyang Liu, Tingting Zhang, Jiahui Sun, Jiuxiu Yao, Lina Ma, Jianhua Fu, Hao Li
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/4b48b4a8a47a461f80379f738be7a6c7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4b48b4a8a47a461f80379f738be7a6c7
record_format dspace
spelling oai:doaj.org-article:4b48b4a8a47a461f80379f738be7a6c72021-12-01T07:12:30ZAn Overview of Systematic Reviews of Chinese Herbal Medicine for Alzheimer’s Disease1663-981210.3389/fphar.2021.761661https://doaj.org/article/4b48b4a8a47a461f80379f738be7a6c72021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.761661/fullhttps://doaj.org/toc/1663-9812Background: Multiple systematic reviews (SRs) have been conducted to evaluate the efficacy and safety of Chinese herbal medicine (CHM) in patients with Alzheimer’s disease (AD). Here, we aim to perform an overview to assess the methodological quality and quality of evidence of the SRs to provide convincing data on the treatment of AD with CHM.Method: Six electronic databases including Chinese and English were searched, until April 31, 2021. Two researchers independently screen documents and extract data according to the predesigned rules. A Measure Tool to Assessment System Reviews 2 (AMSTAR-2) was used to investigate the methodological quality, and the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) was used to determine the quality of evidence for outcomes.Results: Twelve qualified SRs including 163 randomized controlled trials were reviewed. The methodological quality of the included SRs was considered extremely low assessed through AMSTAR-2. Compared with western medicines (WM) alone, CHM as an adjuvant treatment has shown significant effects in improving Mini-mental State Examination, Alzheimer’s Disease Assessment Scale-Cognitive, and Clinical Dementia Rating scores. The same is true for CHM alone. Regarding the effect on Activities Daily Living, neither the single CHM nor the combination with WM has an obvious effect. For the total effective rate, both single CHM and the combination with WM shown significant effects. Nine SRs suggested that CHM as adjuvant therapy or single-use had fewer adverse events than WM. Additionally, the quality of evidence for the main outcome was reviewed as low or extremely low according to GRADE profiler data.Conclusion: Current evidence suggests that CHM may be beneficial in improving the cognitive function of AD patients. However, we should be cautious about the evidence due to methodological flaws and low quality. High-quality RCTs are further needed to confirm the efficacy and safety of CHM for AD.Nanyang LiuTingting ZhangJiahui SunJiuxiu YaoLina MaJianhua FuHao LiHao LiFrontiers Media S.A.articleChinese herbal medicinetraditional Chinese medicineAlzheimer’s diseaseoverviewsystematic review and meta-analysisTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Chinese herbal medicine
traditional Chinese medicine
Alzheimer’s disease
overview
systematic review and meta-analysis
Therapeutics. Pharmacology
RM1-950
spellingShingle Chinese herbal medicine
traditional Chinese medicine
Alzheimer’s disease
overview
systematic review and meta-analysis
Therapeutics. Pharmacology
RM1-950
Nanyang Liu
Tingting Zhang
Jiahui Sun
Jiuxiu Yao
Lina Ma
Jianhua Fu
Hao Li
Hao Li
An Overview of Systematic Reviews of Chinese Herbal Medicine for Alzheimer’s Disease
description Background: Multiple systematic reviews (SRs) have been conducted to evaluate the efficacy and safety of Chinese herbal medicine (CHM) in patients with Alzheimer’s disease (AD). Here, we aim to perform an overview to assess the methodological quality and quality of evidence of the SRs to provide convincing data on the treatment of AD with CHM.Method: Six electronic databases including Chinese and English were searched, until April 31, 2021. Two researchers independently screen documents and extract data according to the predesigned rules. A Measure Tool to Assessment System Reviews 2 (AMSTAR-2) was used to investigate the methodological quality, and the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) was used to determine the quality of evidence for outcomes.Results: Twelve qualified SRs including 163 randomized controlled trials were reviewed. The methodological quality of the included SRs was considered extremely low assessed through AMSTAR-2. Compared with western medicines (WM) alone, CHM as an adjuvant treatment has shown significant effects in improving Mini-mental State Examination, Alzheimer’s Disease Assessment Scale-Cognitive, and Clinical Dementia Rating scores. The same is true for CHM alone. Regarding the effect on Activities Daily Living, neither the single CHM nor the combination with WM has an obvious effect. For the total effective rate, both single CHM and the combination with WM shown significant effects. Nine SRs suggested that CHM as adjuvant therapy or single-use had fewer adverse events than WM. Additionally, the quality of evidence for the main outcome was reviewed as low or extremely low according to GRADE profiler data.Conclusion: Current evidence suggests that CHM may be beneficial in improving the cognitive function of AD patients. However, we should be cautious about the evidence due to methodological flaws and low quality. High-quality RCTs are further needed to confirm the efficacy and safety of CHM for AD.
format article
author Nanyang Liu
Tingting Zhang
Jiahui Sun
Jiuxiu Yao
Lina Ma
Jianhua Fu
Hao Li
Hao Li
author_facet Nanyang Liu
Tingting Zhang
Jiahui Sun
Jiuxiu Yao
Lina Ma
Jianhua Fu
Hao Li
Hao Li
author_sort Nanyang Liu
title An Overview of Systematic Reviews of Chinese Herbal Medicine for Alzheimer’s Disease
title_short An Overview of Systematic Reviews of Chinese Herbal Medicine for Alzheimer’s Disease
title_full An Overview of Systematic Reviews of Chinese Herbal Medicine for Alzheimer’s Disease
title_fullStr An Overview of Systematic Reviews of Chinese Herbal Medicine for Alzheimer’s Disease
title_full_unstemmed An Overview of Systematic Reviews of Chinese Herbal Medicine for Alzheimer’s Disease
title_sort overview of systematic reviews of chinese herbal medicine for alzheimer’s disease
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/4b48b4a8a47a461f80379f738be7a6c7
work_keys_str_mv AT nanyangliu anoverviewofsystematicreviewsofchineseherbalmedicineforalzheimersdisease
AT tingtingzhang anoverviewofsystematicreviewsofchineseherbalmedicineforalzheimersdisease
AT jiahuisun anoverviewofsystematicreviewsofchineseherbalmedicineforalzheimersdisease
AT jiuxiuyao anoverviewofsystematicreviewsofchineseherbalmedicineforalzheimersdisease
AT linama anoverviewofsystematicreviewsofchineseherbalmedicineforalzheimersdisease
AT jianhuafu anoverviewofsystematicreviewsofchineseherbalmedicineforalzheimersdisease
AT haoli anoverviewofsystematicreviewsofchineseherbalmedicineforalzheimersdisease
AT haoli anoverviewofsystematicreviewsofchineseherbalmedicineforalzheimersdisease
AT nanyangliu overviewofsystematicreviewsofchineseherbalmedicineforalzheimersdisease
AT tingtingzhang overviewofsystematicreviewsofchineseherbalmedicineforalzheimersdisease
AT jiahuisun overviewofsystematicreviewsofchineseherbalmedicineforalzheimersdisease
AT jiuxiuyao overviewofsystematicreviewsofchineseherbalmedicineforalzheimersdisease
AT linama overviewofsystematicreviewsofchineseherbalmedicineforalzheimersdisease
AT jianhuafu overviewofsystematicreviewsofchineseherbalmedicineforalzheimersdisease
AT haoli overviewofsystematicreviewsofchineseherbalmedicineforalzheimersdisease
AT haoli overviewofsystematicreviewsofchineseherbalmedicineforalzheimersdisease
_version_ 1718405410309799936